About EuroAPI

Company Description

Euroapi is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world.

We are a world leader in active pharmaceutical ingredients with some 200 products in our portfolio, offering a large span of technologies, while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO).

Year founded

2021

Served area

Worldwide

Headcount

3,350

Headquarters

15 Rue Traversière, 75012 Paris – France

Shareholder information

Shares outstanding

94,026,888

IPO

May 6, 2022

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.